Skip to content

Prospective Single-Arm Trial of Robot-Assisted Gasless vNOTES Radical Hysterectomy Under Ureteral Fluorescence Imaging

Prospective Single-Arm Trial of Robot-Assisted Gasless vNOTES Radical Hysterectomy Under Ureteral Fluorescence Imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112974
Enrollment
Unknown
Registered
2025-11-21
Start date
2025-11-24
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Experimental group:Undergo robot-assisted gasless vNOTES radical hysterectomy with ureteral fluorescence tracing

Sponsors

Chengdu Women's and Children's Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Female patients aged 40-80 years; 2.Patients with pathologically confirmed cervical cancer at stage ?A-?A, meeting the indications for radical hysterectomy, and scheduled to undergo robot-assisted gasless vNOTES radical hysterectomy; 3.Patients classified as Grade ?-? according to the American Society of Anesthesiologists (ASA) Physical Status Classification System; 4.Patients who can cooperate in completing the visits and related examinations as specified in the protocol; 5.Patients and their family members have fully understood the purpose, process, and risks of this study, and voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.A history of severe pelvic or abdominal adhesions that may affect surgical procedures; 2.Comorbidity with other malignant tumors; 3.Patients with positive antibodies to human immunodeficiency virus (HIV); positive antibodies to hepatitis C virus (HCV); or positive antibodies to Treponema pallidum (syphilis) who are judged by the researcher to have a high risk of transmission; 4.Patients with severe systemic diseases who are deemed unsuitable for surgical treatment by the researcher; 5.Allergies to fluorescent tracers (such as indocyanine green); 6.Patients with mental illness who are unable to cooperate with the study; 7.Other circumstances deemed inappropriate for participation in this trial by the researcher.

Design outcomes

Secondary

MeasureTime frame
Intraoperative Complication Rate;Surgical Success Rate;Postoperative Recovery Indicators;Tumor Recurrence Status;Postoperative Quality of Life;

Primary

MeasureTime frame
Fluorescent tracing effect;

Countries

China

Contacts

Public ContactLin Yonghong

Chengdu Women's and Children's Central Hospital

1595669008@qq.com+86 28 6186 6118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026